An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector With a Pre-Filled Liquid Avonex Syringe in Multiple Sclerosis Subjects.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
- Sponsors Biogen
- 19 Feb 2010 Planned end date changed from 1 Jan 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.(NCT00828204)
- 13 Aug 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 10 Jul 2009 Actual initiation date changed from Aug 2005 to Dec 2008 as reported by ClinicalTrials.gov.